• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益生菌加益生元补充剂对根除四联疗法耐受性和疗效的影响:一项随机前瞻性双盲对照试验。

The Effect of Probiotic Plus Prebiotic Supplementation on the Tolerance and Efficacy of Eradication Quadruple Therapy: a Randomized Prospective Double Blind Controlled Trial.

作者信息

Shafaghi Afshin, Pourkazemi Aydin, Khosravani Mohsen, Fakhrie Asl Saba, Amir Maafi Alireza, Atrkar Roshan Zahra, Abaspour Rahimabad Jafar

机构信息

Member of Gastrointestinal and Liver Diseases Research Center(GLDRC) and Gastroenterology Department, Guilan University of Medical Sciences, Rasht, Iran gjhsdfgjfdh.

Infectious Disease Department, Guilan University of Medical Sciences, Rasht, Iran.

出版信息

Middle East J Dig Dis. 2016 Jul;8(3):179-188. doi: 10.15171/mejdd.2016.30.

DOI:10.15171/mejdd.2016.30
PMID:27698967
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5045670/
Abstract

BACKGROUND Standard anti-H () treatment fails in the eradication of the organism in almost 10-35% of the patients and has different side effects. Recent studies have proposed that probiotic supplementations with or without prebiotic may improve the eradication rate and diminish the side effects, although it is still a controversial issue. We aimed to investigate the effect of probiotic with prebiotic supplementation on the eradication rate and side effects of anti quadruple therapy. METHODS 76 patients with a positive biopsy specimen for were enrolled. They were randomized to receive quadruple therapy of bismuth, clarithromycin, amoxicillin, and omeprazole for 14 days and also the synbiotic or the placebo. We asked them to answer study questionnaires at the beginning and during the treatment. Finally, urea breath test was done 8 weeks after the treatment. RESULTS The eradication rate was significantly better in the synbiotic group by intention-to-treat analysis (p<0.05). Treatment side effects such as diarrhea, nausea, vomiting, epigastric pain, flatulence, constipation, and taste abnormality were similar in both groups but anorexia was significantly better in the synbiotic group (p <0.05). CONCLUSION The eradication rate was significantly better in the synbiotic group by intention-to-treat analysis (p<0.05). Treatment side effects such as diarrhea, nausea, vomiting, epigastric pain, flatulence, but could improve the eradication by augmenting the treatment tolerance and compliance.

摘要

背景

标准的抗幽门螺杆菌(H)治疗在近10%-35%的患者中无法根除该病菌,且有不同的副作用。近期研究表明,补充益生菌(无论是否添加益生元)可能会提高根除率并减少副作用,尽管这仍是一个有争议的问题。我们旨在研究补充益生菌和益生元对根除率及抗幽门螺杆菌四联疗法副作用的影响。方法:招募了76例活检标本幽门螺杆菌呈阳性的患者。他们被随机分为两组,一组接受铋剂、克拉霉素、阿莫西林和奥美拉唑的四联疗法治疗14天,并同时服用合生元或安慰剂。我们要求他们在治疗开始时和治疗期间回答研究问卷。最后,在治疗8周后进行尿素呼气试验。结果:意向性分析显示,合生元组的根除率显著更高(p<0.05)。两组的腹泻、恶心、呕吐、上腹部疼痛、肠胃胀气、便秘和味觉异常等治疗副作用相似,但合生元组的食欲不振情况明显更好(p<0.05)。结论:意向性分析显示,合生元组的根除率显著更高(p<0.05)。腹泻、恶心、呕吐、上腹部疼痛、肠胃胀气等治疗副作用虽相似,但合生元可通过提高治疗耐受性和依从性来提高根除率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ee3/5045670/8a356ee164b1/mejdd-8-179-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ee3/5045670/8a356ee164b1/mejdd-8-179-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ee3/5045670/8a356ee164b1/mejdd-8-179-g001.jpg

相似文献

1
The Effect of Probiotic Plus Prebiotic Supplementation on the Tolerance and Efficacy of Eradication Quadruple Therapy: a Randomized Prospective Double Blind Controlled Trial.益生菌加益生元补充剂对根除四联疗法耐受性和疗效的影响:一项随机前瞻性双盲对照试验。
Middle East J Dig Dis. 2016 Jul;8(3):179-188. doi: 10.15171/mejdd.2016.30.
2
[Quadruple regimens using domestically manufactured drugs in gastritis and duodenal ulcer patients for Helicobacter pylori eradication: a perspective, multicenter, randomized controlled trial].[使用国产药物的四联疗法根除胃炎和十二指肠溃疡患者幽门螺杆菌:一项前瞻性、多中心、随机对照试验]
Zhonghua Yi Xue Za Zhi. 2016 Jan 26;96(4):260-4. doi: 10.3760/cma.j.issn.0376-2491.2016.04.006.
3
Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study.不同益生菌制剂对幽门螺杆菌治疗相关副作用的影响:一项平行组、三盲、安慰剂对照研究。
Am J Gastroenterol. 2002 Nov;97(11):2744-9. doi: 10.1111/j.1572-0241.2002.07063.x.
4
[Influence of different timing of combined with bismuth quadruple therapy for eradication].[不同时间点联合铋剂四联疗法根除幽门螺杆菌的疗效观察] (备注:原文标题不完整,推测是关于幽门螺杆菌根除相关研究,补充了“幽门螺杆菌”使标题更完整表意,具体需结合完整文献内容确定准确含义)
Zhonghua Yi Xue Za Zhi. 2019 Jun 11;99(22):1731-1734. doi: 10.3760/cma.j.issn.0376-2491.2019.22.010.
5
The effects of multistrain probiotic compound on bismuth-containing quadruple therapy for Helicobacter pylori infection: a randomized placebo-controlled triple-blind study.多菌株益生菌复合制剂对含铋四联疗法治疗幽门螺杆菌感染的影响:一项随机安慰剂对照三盲研究。
Helicobacter. 2013 Aug;18(4):280-4. doi: 10.1111/hel.12047. Epub 2013 Feb 24.
6
Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials.补充益生菌治疗幽门螺杆菌根除的疗效:一项随机对照试验的荟萃分析。
PLoS One. 2016 Oct 10;11(10):e0163743. doi: 10.1371/journal.pone.0163743. eCollection 2016.
7
Helicobacter pylori eradication with ecabet sodium, omeprazole, amoxicillin, and clarithromycin versus bismuth, omeprazole, amoxicillin, and clarithromycin quadruple therapy: a randomized, open-label, phase IV trial.埃卡倍特钠、奥美拉唑、阿莫西林和克拉霉素三联疗法与铋剂、奥美拉唑、阿莫西林和克拉霉素四联疗法根除幽门螺杆菌的随机、开放标签、四期临床试验。
Helicobacter. 2012 Dec;17(6):458-65. doi: 10.1111/j.1523-5378.2012.00971.x. Epub 2012 Jul 2.
8
Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial.铋剂四联疗法(含阿莫西林或四环素)与奥美拉唑、甲硝唑三联疗法作为一线治疗方案根除十二指肠溃疡患者幽门螺杆菌的疗效和耐受性:一项随机临床试验。
PLoS One. 2018 Jun 11;13(6):e0197096. doi: 10.1371/journal.pone.0197096. eCollection 2018.
9
Probiotic supplementation with Lactobacillus plantarum and Pediococcus acidilactici for Helicobacter pylori therapy: A randomized, double-blind, placebo-controlled trial.植物乳杆菌和戊糖片球菌联合益生菌补充治疗幽门螺杆菌:一项随机、双盲、安慰剂对照试验。
Helicobacter. 2018 Oct;23(5):e12529. doi: 10.1111/hel.12529. Epub 2018 Aug 23.
10
Combined With Quadruple Therapy for Eradication Decreased the Duration and Severity of Diarrhea: A Multi-Center Prospective Randomized Controlled Trial.联合四联疗法根除治疗可缩短腹泻持续时间并减轻腹泻严重程度:一项多中心前瞻性随机对照试验
Front Med (Lausanne). 2021 Nov 18;8:776955. doi: 10.3389/fmed.2021.776955. eCollection 2021.

引用本文的文献

1
Efficacy of probiotics pretreatment in eradication therapy: a systematic review and meta-analysis of clinical outcomes.益生菌预处理在根除治疗中的疗效:临床结局的系统评价和荟萃分析
Ann Med. 2025 Dec;57(1):2533431. doi: 10.1080/07853890.2025.2533431. Epub 2025 Jul 23.
2
Towards Effective Eradication: Emerging Therapies in the Wake of Antibiotic Resistance.迈向有效根除:抗生素耐药性背景下的新兴疗法
Int J Mol Sci. 2025 Jun 24;26(13):6064. doi: 10.3390/ijms26136064.
3
Biotics and Children's and Adolescents' Health: A Narrative Review.

本文引用的文献

1
Meta-analysis of the efficacy of probiotics in Helicobacter pylori eradication therapy.益生菌在幽门螺杆菌根除治疗中疗效的荟萃分析。
World J Gastroenterol. 2014 Dec 21;20(47):18013-21. doi: 10.3748/wjg.v20.i47.18013.
2
The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: a meta-analysis.补充益生菌对幽门螺杆菌根除率及根除治疗期间副作用的影响:一项荟萃分析。
PLoS One. 2014 Nov 3;9(11):e111030. doi: 10.1371/journal.pone.0111030. eCollection 2014.
3
Probiotic/synbiotic therapy for treating critically ill patients from a gut microbiota perspective.
生物制剂与儿童及青少年健康:一篇叙述性综述
Children (Basel). 2024 Mar 9;11(3):329. doi: 10.3390/children11030329.
4
The Role of Probiotics in the Eradication of Helicobacter pylori and Overall Impact on Management of Peptic Ulcer: A Study Involving Patients Undergoing Triple Therapy in Bangladesh.益生菌在根除幽门螺杆菌中的作用及对消化性溃疡治疗的总体影响:一项针对孟加拉国接受三联疗法患者的研究
Cureus. 2024 Mar 16;16(3):e56283. doi: 10.7759/cureus.56283. eCollection 2024 Mar.
5
Efficacy and safety of probiotic-supplemented bismuth quadruple therapy for the treatment of infection: a systematic review and meta-analysis.益生菌补充铋四联疗法治疗 感染的疗效和安全性:系统评价和荟萃分析。
J Int Med Res. 2023 Oct;51(10):3000605231203841. doi: 10.1177/03000605231203841.
6
Gastric microbiota: an emerging player in gastric cancer.胃微生物群:胃癌中一个新出现的因素
Front Microbiol. 2023 Apr 27;14:1130001. doi: 10.3389/fmicb.2023.1130001. eCollection 2023.
7
2022 Chinese national clinical practice guideline on Helicobacter pylori eradication treatment.2022 中国国家临床实践指南:幽门螺杆菌根除治疗。
Chin Med J (Engl). 2022 Dec 20;135(24):2899-2910. doi: 10.1097/CM9.0000000000002546.
8
Evaluation of the Potential Protective Effects of Strains against Infection: A Randomized, Double-Blinded, Placebo-Controlled Trial.菌株抗感染潜在保护作用的评估:一项随机、双盲、安慰剂对照试验。
Can J Infect Dis Med Microbiol. 2022 Sep 23;2022:6432750. doi: 10.1155/2022/6432750. eCollection 2022.
9
The interplay between and the gut microbiota: An emerging driver influencing the immune system homeostasis and gastric carcinogenesis.与肠道微生物群的相互作用:影响免疫系统稳态和胃癌发生的新兴驱动因素。
Front Cell Infect Microbiol. 2022 Aug 15;12:953718. doi: 10.3389/fcimb.2022.953718. eCollection 2022.
10
Probiotics, Their Extracellular Vesicles and Infectious Diseases.益生菌、其细胞外囊泡与传染病
Front Microbiol. 2022 Mar 30;13:864720. doi: 10.3389/fmicb.2022.864720. eCollection 2022.
从肠道微生物群角度探讨益生菌/合生菌治疗危重症患者。
Dig Dis Sci. 2013 Jan;58(1):23-32. doi: 10.1007/s10620-012-2334-x. Epub 2012 Aug 19.
4
Metagenomics and probiotics.宏基因组学与益生菌。
Clin Microbiol Infect. 2012 Jul;18 Suppl 4:32-4. doi: 10.1111/j.1469-0691.2012.03873.x.
5
Optimal therapy for Helicobacter pylori infections.幽门螺杆菌感染的最佳治疗方法。
Nat Rev Gastroenterol Hepatol. 2011 Feb;8(2):79-88. doi: 10.1038/nrgastro.2010.210.
6
The effect of probiotics and mucoprotective agents on PPI-based triple therapy for eradication of Helicobacter pylori.益生菌和黏液保护剂对基于质子泵抑制剂的三联疗法根除幽门螺杆菌的影响。
Helicobacter. 2010 Jun;15(3):206-13. doi: 10.1111/j.1523-5378.2010.00751.x.
7
Clinical practice. Helicobacter pylori infection.临床实践。幽门螺杆菌感染。
N Engl J Med. 2010 Apr 29;362(17):1597-604. doi: 10.1056/NEJMcp1001110.
8
Effect of Helicobacter pylori infection on IL-8, IL-1beta and COX-2 expression in patients with chronic gastritis and gastric cancer.幽门螺杆菌感染对慢性胃炎和胃癌患者白细胞介素-8、白细胞介素-1β和环氧化酶-2表达的影响。
Scand J Gastroenterol. 2009;44(2):153-61. doi: 10.1080/00365520802530853.
9
Synbiotics decrease the incidence of septic complications in patients with severe SIRS: a preliminary report.合生元可降低重症全身炎症反应综合征患者脓毒症并发症的发生率:初步报告。
Dig Dis Sci. 2009 May;54(5):1071-8. doi: 10.1007/s10620-008-0460-2. Epub 2008 Aug 23.
10
Molecular characterization of Helicobacter pylori VacA induction of IL-8 in U937 cells reveals a prominent role for p38MAPK in activating transcription factor-2, cAMP response element binding protein, and NF-kappaB activation.幽门螺杆菌空泡毒素A(VacA)诱导U937细胞产生白细胞介素-8(IL-8)的分子特征揭示了p38丝裂原活化蛋白激酶(p38MAPK)在激活转录因子2、环磷酸腺苷反应元件结合蛋白(CREB)和核因子κB(NF-κB)活化过程中的重要作用。
J Immunol. 2008 Apr 1;180(7):5017-27. doi: 10.4049/jimmunol.180.7.5017.